{"filing":{"accession_number":"0001809519-26-000133","cik":"0001809519","ticker":"GDRX","company_name":"GoodRx Holdings, Inc.","form":"8-K","filing_date":"2026-06-18","report_date":null,"primary_document":"gdrx-20260616.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1809519/000180951926000133/gdrx-20260616.htm"},"events":[{"id":11870,"run_id":10444,"accession_number":"0001809519-26-000133","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This is a clear disclosure of shareholder voting results from GoodRx's Annual Meeting of Stockholders held on June 16, 2026. The filing reports final vote tallies for three proposals: election of three Class III directors (Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote counts (FOR, AGAINST, WITHHELD, ABSTAINED) and broker non-votes for each proposal, with all three proposals passing. This is a quintessential Item 5.07 shareholder vote results disclosure.","company_name":"GoodRx Holdings, Inc.","ticker":"GDRX","filing_date":"2026-06-18","form":"8-K","submitted_at":null,"items":[{"id":8570,"accession_number":"0001809519-26-000133","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from GoodRx's Annual Meeting of Stockholders held on June 16, 2026. The filing reports final vote tallies for three proposals: election of three Class III directors (Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote counts (FOR, AGAINST, WITHHELD, ABSTAINED) and broker non-votes for each proposal, with all three proposals passing. This is a quintessential Item 5.07 shareholder vote results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:20:35.817806+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":8570,"accession_number":"0001809519-26-000133","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This is a clear disclosure of shareholder voting results from GoodRx's Annual Meeting of Stockholders held on June 16, 2026. The filing reports final vote tallies for three proposals: election of three Class III directors (Wendy Barnes, Ronald E. Bruehlman, and Gregory Mondre), ratification of KPMG LLP as independent auditor, and advisory approval of named executive officer compensation. The disclosure includes vote counts (FOR, AGAINST, WITHHELD, ABSTAINED) and broker non-votes for each proposal, with all three proposals passing. This is a quintessential Item 5.07 shareholder vote results disclosure.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-18T20:20:35.817806+00:00","company_name":"GoodRx Holdings, Inc.","ticker":"GDRX","filing_date":"2026-06-18"}]}